Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
Sexual Problems Common in Arthritis Patients Dysfunction, loss of intimacy mostly go unaddressed Apr 03, 2019
For RA With COPD, Abatacept is Safe No increased pulmonary risks compared with other biologics Mar 21, 2019
No Rise in Cancer Risk for RA Patients on Actemra Similar to malignancy risk with TNF inhibitors and abatacept Mar 14, 2019
'Not a Haircut': Two Knees, Same Day ... More Risk? Evidence, experience mixed on simultaneous bilateral knee replacement Feb 14, 2019
Stopping Biologics Before Joint Surgery: Is Earlier Better? For abatacept, one dosing interval sufficed in RA patients Feb 12, 2019
Does Methotrexate Work in Giant Cell Arteritis? Methotrexate add-on to glucocorticoid decreased rate of subsequent relapse by nearly two-fold Jan 26, 2019
IBD Rates Low in Patients on Cosentyx Analysis of data from 21 clinical trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis Jan 25, 2019
Targeting IL-1 Fails in Knee OA Little benefit seen for lutikizumab on scores for pain and function Jan 23, 2019
Combo Biologics in RA? Be Cautious Risk of adverse events appeared to be less with tapered doses Dec 27, 2018
Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
Infection Risk Lower With Orencia vs Anti-TNF Increased risk for hospitalized infection with TNF inhibitors was driven largely by infliximab Dec 26, 2018
Good News for Pregnant Women With Psoriatic Arthritis No adverse effect on birth outcomes, and many reported fewer joint symptoms during pregnancy Dec 22, 2018
IL-1 Blocker Fails for Hand Osteoarthritis Pain, function, and structural changes were similar to placebo Dec 20, 2018
PASDAS: Targeting Multiple Aspects of PsA Secukinumab showed efficacy for the various domains of psoriatic arthritis Dec 10, 2018
ACR: Can Tanezumab Be Revived for OA? Low incidence of rapidly progressive OA seen with lower doses Oct 26, 2018
In Psoriatic Arthritis, Doubling Down on IL-17 Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
RA Guideline Adherence Spotty, Study Finds Treat-to-target recommendation not followed for half of patients Oct 23, 2018
New JAK1 Agent Beats Humira in Rheumatoid Arthritis Thrombotic events balanced between upadacitinib, adalimumab, and placebo Oct 22, 2018
Understanding Neuropathic-Like Knee Pain Central risk factors may contribute to the condition, study shows Oct 13, 2018
Repeat CRP Tests If Spine Disease Uncertain Post-hoc analysis of patients with axial spondyloarthritis Sep 17, 2018
Nurses Can Lead the Way in Research ACR and EULAR studies demonstrated that research "is an important part of what we do" Aug 11, 2018
Minimal Disease Activity: The Goal in PsA Validity confirmed in large population of patients Jul 19, 2018
Enthesitis in PsA: A New Focus of Treatment? Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
Cardiovascular Risk in RA: Beyond Inflammation? With adverse lifestyle plus bad genes plus inflammation, 'you unleash hell' Jun 16, 2018
Weight, Smoking Inhibit RA Remission Factors differ for women and men, but both relate to lifestyle Jun 15, 2018
Meds Improve Cardiovascular Risk in RA Benefits seen for hydroxychloroquine, methotrexate, and tocilizumab Jun 15, 2018
Inflammatory Eye Disease: Complex, Scary Often related to autoimmune, inflammatory diseases May 10, 2018
RA Therapy: After Methotrexate, Then What? Strong preference for anti-TNF therapy despite emerging data May 09, 2018
Tocilizumab Beats Anti-TNFs for Treatment Retention Longer time on treatment, regardless of additional DMARDs May 08, 2018
RA Patients Pose Perioperative Challenges Expert discusses risk evaluation, stopping antirheumatic drugs May 07, 2018
Biosimilar Switch Succeeds in Single Center Disease activity scores improved significantly after the change in rheumatoid arthritis patients May 04, 2018
Shocker! Is Vioxx Coming Back... as an Orphan Drug? Milton Packer wonders whether its return represents innovation or opportunism May 02, 2018
Troponin Predicts Mortality in Inflammatory Arthritis High levels associated with all-cause and cardiovascular death May 01, 2018
FDA Panel Gives Celecoxib Positive CV Safety Grade Votes 15-5 that it is non-inferior to naproxen, ibuprofen Apr 25, 2018